People | September 19, 2023
Biocon names Peter Bains as Group CEO
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The inspection was a cGMP Inspection and had ended with NIL observations
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
Subscribe To Our Newsletter & Stay Updated
